Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Delisted patents from the Rx, OTC, and Disc drug lists are displayed in individual tables below.


The following search results are a list of patents that have been DELISTED from the latest Edition (delistings since January 27, 2009 ) of the Orange Book. Search results display delisted patents from drug products on the RX list.

Appl No Prod No Active Ingredient Proprietary Name Delisted Patent
N020886 001 ALITRETINOIN PANRETIN 7056954

N021515 001 BUPROPION HYDROCHLORIDE WELLBUTRIN XL 6143327

N020297 002 CARVEDILOL COREG 5902821

N020297 002 CARVEDILOL COREG 5902821*PED

N020297 003 CARVEDILOL COREG 5902821

N020297 003 CARVEDILOL COREG 5902821*PED

N020297 004 CARVEDILOL COREG 5902821

N020297 004 CARVEDILOL COREG 5902821*PED

N020297 001 CARVEDILOL COREG 5902821

N020297 001 CARVEDILOL COREG 5902821*PED

N021041 001 CYTARABINE DEPOCYT 5962016

N020862 001 DOXERCALCIFEROL HECTOROL 5707980

N021687 004 EZETIMIBE; SIMVASTATIN VYTORIN 7229982

N021687 004 EZETIMIBE; SIMVASTATIN VYTORIN 7229982*PED

N021687 003 EZETIMIBE; SIMVASTATIN VYTORIN 7229982

N021687 003 EZETIMIBE; SIMVASTATIN VYTORIN 7229982*PED

N021687 002 EZETIMIBE; SIMVASTATIN VYTORIN 7229982

N021687 002 EZETIMIBE; SIMVASTATIN VYTORIN 7229982*PED

N021687 001 EZETIMIBE; SIMVASTATIN VYTORIN 7229982

N021687 001 EZETIMIBE; SIMVASTATIN VYTORIN 7229982*PED

N019884 001 MESNA MESNEX 5696172

N021332 001 PRAMLINTIDE ACETATE SYMLIN 5175145

N021332 001 PRAMLINTIDE ACETATE SYMLIN 6410511

N021546 001 RIBAVIRIN REBETOL 6063772*PED

N021546 001 RIBAVIRIN REBETOL 5767097

N021546 001 RIBAVIRIN REBETOL 5767097*PED

N021546 001 RIBAVIRIN REBETOL 6063772

N020903 001 RIBAVIRIN REBETOL 6335032*PED

N020903 001 RIBAVIRIN REBETOL 6337090

N020903 001 RIBAVIRIN REBETOL 6337090*PED

N020903 001 RIBAVIRIN REBETOL 6063772

N020903 001 RIBAVIRIN REBETOL 6063772*PED

N020903 001 RIBAVIRIN REBETOL 6335032

N020903 001 RIBAVIRIN REBETOL 5914128*PED

N020903 001 RIBAVIRIN REBETOL 6051252

N020903 001 RIBAVIRIN REBETOL 6051252*PED

N020903 001 RIBAVIRIN REBETOL 5767097

N020903 001 RIBAVIRIN REBETOL 5767097*PED

N020903 001 RIBAVIRIN REBETOL 5914128

N020903 002 RIBAVIRIN REBETOL 6337090

N020903 002 RIBAVIRIN REBETOL 6337090*PED

N020903 002 RIBAVIRIN REBETOL 6063772*PED

N020903 002 RIBAVIRIN REBETOL 6335032

N020903 002 RIBAVIRIN REBETOL 6335032*PED

N020903 002 RIBAVIRIN REBETOL 6051252

N020903 002 RIBAVIRIN REBETOL 6051252*PED

N020903 002 RIBAVIRIN REBETOL 6063772

N020903 002 RIBAVIRIN REBETOL 5767097*PED

N020903 002 RIBAVIRIN REBETOL 5914128

N020903 002 RIBAVIRIN REBETOL 5914128*PED

N020903 002 RIBAVIRIN REBETOL 5767097

N021346 001 RISPERIDONE RISPERDAL CONSTA 6110503

N021346 001 RISPERIDONE RISPERDAL CONSTA 6110503*PED

N021346 003 RISPERIDONE RISPERDAL CONSTA 6110503

N021346 003 RISPERIDONE RISPERDAL CONSTA 6110503*PED

N021346 002 RISPERIDONE RISPERDAL CONSTA 6110503

N021346 002 RISPERIDONE RISPERDAL CONSTA 6110503*PED

N020132 003 SUMATRIPTAN SUCCINATE IMITREX 6020001*PED

N020132 003 SUMATRIPTAN SUCCINATE IMITREX 6368627

N020132 003 SUMATRIPTAN SUCCINATE IMITREX 6368627*PED

N020132 003 SUMATRIPTAN SUCCINATE IMITREX 5863559

N020132 003 SUMATRIPTAN SUCCINATE IMITREX 5863559*PED

N020132 003 SUMATRIPTAN SUCCINATE IMITREX 6020001

N020132 002 SUMATRIPTAN SUCCINATE IMITREX 6020001*PED

N020132 002 SUMATRIPTAN SUCCINATE IMITREX 6368627

N020132 002 SUMATRIPTAN SUCCINATE IMITREX 6368627*PED

N020132 002 SUMATRIPTAN SUCCINATE IMITREX 5863559

N020132 002 SUMATRIPTAN SUCCINATE IMITREX 5863559*PED

N020132 002 SUMATRIPTAN SUCCINATE IMITREX 6020001

N020132 001 SUMATRIPTAN SUCCINATE IMITREX 6020001*PED

N020132 001 SUMATRIPTAN SUCCINATE IMITREX 6368627

N020132 001 SUMATRIPTAN SUCCINATE IMITREX 6368627*PED

N020132 001 SUMATRIPTAN SUCCINATE IMITREX 5863559

N020132 001 SUMATRIPTAN SUCCINATE IMITREX 5863559*PED

N020132 001 SUMATRIPTAN SUCCINATE IMITREX 6020001




The following search results are a list of patents that have been DELISTED from the latest Edition (delistings since January 27, 2009 ) of the Orange Book. Search results display delisted patents from drug products on the OTC list.

Appl No Prod No Active Ingredient Proprietary Name Delisted Patent
N020958 001 CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE PEPCID COMPLETE 5817340

N020958 001 CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE PEPCID COMPLETE 5817340*PED

N021140 001 LOPERAMIDE HYDROCHLORIDE; SIMETHICONE IMODIUM MULTI-SYMPTOM RELIEF 5248505

N021140 001 LOPERAMIDE HYDROCHLORIDE; SIMETHICONE IMODIUM MULTI-SYMPTOM RELIEF 5612054




There have been no patent delistings from the Orange Book in the DISC list since the last Annual Edition.


Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:
    Orange Book Data - Monthly
    Generic Drug Product Information & Patent Information - Daily
    Orange Book Data Updated Through December, 2009
    Patent and Generic Drug Product Data Last Updated: February 04, 2010
 
-
-
-
-
-